
Paclibenz Injection
Marketer
Admac Pharma Ltd
Salt Composition
Paclitaxel (100mg/ml)
Overview Paclibenz Injection
Paclibenz Injection is a chemotherapeutic agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects may not be immediately apparent, lasting several weeks or months, discontinuation should only occur under medical supervision. Common side effects include nausea, emesis, and fatigue; more serious reactions such as peripheral edema, alopecia, and weight increase are possible. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising or bleeding, pharyngitis, oral ulcers, or pyrexia immediately. Paclibenz can suppress blood cell production, increasing infection risk, necessitating regular blood counts and liver function tests. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all current medications, including antibiotics, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout the treatment period.
Uses of Paclibenz Injection
Cancers of the breast, lung (non-small cell), and pancreas.
Major Benefits of Paclibenz Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Paclibenz Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Paclibenz Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Paclibenz Injection works:
Paclibenz Injection is a chemotherapy agent that targets microtubules, essential components of cancer cell division. By disrupting these structures, it inhibits cancer cell proliferation, leading to their eventual demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining Paclibenz Injection with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Paclibenz Injection during pregnancy is contraindicated due to confirmed harm to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known risks. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Paclibenz Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Paclibenz Injection may induce side effects that could impair your driving ability. While there's no inherent prohibition on driving between treatment cycles, the presence of alcohol in this medication suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Paclibenz Injection poses no safety concerns for individuals with kidney disease, and no dosage modification is necessary. Nevertheless, patients with pre-existing kidney conditions should consult their physician.
LiverCAUTION
Patients with liver impairment should receive Paclibenz Injection with careful monitoring. Dosage modification may be necessary. Physician consultation is advised. Paclibenz Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Paclibenz Injection :
NA
Facts to Know About Paclibenz Injection
| Label | Value |
|---|---|
| Type of Compound | Taxane-based compounds |
| Addictive | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Microtubule-targeting drugs: Taxane class |
